Ashutosh has over 25 years of entrepreneurial experience in building and scaling businesses to global leadership. Ashutosh was the Joint Managing Director of Famy Care Limited before its sale to Mylan Pharmaceuticals and played a pivotal role in making it a global major in Women’s Healthcare. Ashutosh led the manufacturing operations, supply chain management, marketing activities in the regulated markets and strategic initiatives for the Group. Ashutosh also manages the Guardian Pharmacy and GNC India business which has scaled tremendously over the years since its acquisition in 2016. Ashutosh also leads public markets investments and new business ventures for the Taparia Group which has emerged as one of the most well-respected value creation entrepreneurial stories out of India. Ashutosh is an MBA from University of Texas, USA.
Disclaimer
“It has come to our notice that unscrupulous persons are using Ananta Capital name and logo and are luring individuals to open account with them and are taking money from such customers for investing in IPO/Shares trading . They are thus falsely inducing the public and are fraudulently taking money from innocent individuals using Ananta Capital / Ananta Capital Ventures name and logo . Also fake groups on social media such as “Telegram App” are being created giving investment advise and luring innocent individuals using Ananta Ventures / Ananta Capital Ventures name.
We hereby inform to the public at large that we have not invited money from third party individual investors and have no plans to do so . We do not have any website and we are not inviting public (individuals) to invest in our Fund. This is only a captive family investment vehicle. Please do not invest through such fake websites which are using Famy Ananta name and logo . We request public at large not to deal with such fraudulent individuals on fake website and if they do so, it will be at their own risk and we will not be responsible for any consequences thereof”
© Copyright 2021 Ananta Capital. All Rights Reserved.